Company / Operating Income per Share
Processa Pharmaceuticals, Inc. Operating Income per Share History
FY2021-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$0.77
FY2022
5-year range
-$1.07 / -$0.77
FY2021-FY2022
Trend
+27.6%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
-0.77 in FY2022.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, operating income per share increased 27.6% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -4.39 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | -$0.77 | +27.6% |
| FY2021 | -$1.07 | - |
| FY2016 | - | - |
| FY2015 | - | - |
| FY2014 | - | - |
| FY2013 | - | - |
As of FY2022 · SEC 10-K · Updated Jun 28, 2026